Susquehanna International Group
IMDZ

Susquehanna International Group’s Immune Design Corp. IMDZ Stock Holding History

Susquehanna International Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,600
Closed -$74K – 11361
2019
Q1 		$74K Buy
+12,600
New +$42.9K ﹤0.01% 8365
2018
Q4 		– Sell
-51,600
Closed -$178K – 10774
2018
Q3 		$178K Sell
51,600
-24,600
-32% -$92.4K ﹤0.01% 8312
2018
Q2 		$347K Buy
+76,200
New +$304K ﹤0.01% 7557
2017
Q4 		– Sell
-26,800
Closed -$277K – 10486
2017
Q3 		$277K Buy
+26,800
New +$264K ﹤0.01% 7534
2017
Q2 		– Sell
-55,900
Closed -$380K – 10460
2017
Q1 		$380K Buy
+55,900
New +$323K ﹤0.01% 6984
2016
Q2 		– Sell
-10,100
Closed -$131K – 10100
2016
Q1 		$131K Buy
+10,100
New +$117K ﹤0.01% 8303

Susquehanna International Group's IMDZ Position: Q1 2019 in Review

Susquehanna International Group sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 35,287 shares — an estimated $120K sold.

Susquehanna International Group first reported a position in IMDZ in Q4 2016 and held it in 5 quarters. The position peaked at $170K in Q1 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • Susquehanna International Group reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • Susquehanna International Group sold 35,287 Immune Design Corp. shares in Q1 2019, an estimated $120K.
  • Susquehanna International Group first reported a position in Immune Design Corp. in Q4 2016 and held it in 5 quarters.
  • Susquehanna International Group's Immune Design Corp. position peaked at $170K in Q1 2018.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.